Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
Core EBITDA Growth

    Back to All Ratios
SHREE GANESH REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 85.7612.4336.504.0852.65

What is the latest Core EBITDA Growth ratio of SHREE GANESH REMEDIES ?

The latest Core EBITDA Growth ratio of SHREE GANESH REMEDIES is 85.76 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202485.76
Mar202312.43
Mar202236.50
Mar20214.08
Mar202052.65

How is Core EBITDA Growth of SHREE GANESH REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2024 85.76
589.94
Mar2023 12.43
-65.95
Mar2022 36.5
794.61
Mar2021 4.08
-92.25
Mar2020 52.65 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare Core EBITDA Growth ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹879.0 Cr -5.1% 2.4% 1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

-5.1%

2.4%

1%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses